Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Matagne

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Epilepsy Research|August 2, 2002
Use of epileptic animals for adverse effect testingHenrik Klitgaard, Alain Matagne, Yves Lamberty
Epilepsy Research|February 1, 2011
The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticusClaude G Wasterlain, Thomas Stöhr, Alain Matagne
European Journal of Pharmacology|May 18, 2011
Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant propertiesMichel Gillard, Bruno Fuks, Karine Leclercq, et al.
Brain Research Bulletin|August 30, 2008
Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in ratsDoru-Georg Margineanu, Alain Matagne, Rafal M Kaminski, et al.
Epilepsia|June 12, 2013
Synergism of lacosamide with established antiepileptic drugs in the 6-Hz seizure model in miceAlexey Shandra, Pavel Shandra, Olga Kaschenko, et al.
Epilepsy Research|September 28, 2002
Pilocarpine-induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterationsHenrik Klitgaard, Alain Matagne, Jocelyne Vanneste-Goemaere, et al.
Epilepsia|July 17, 2008
Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetamRafal M Kaminski, Alain Matagne, Philip N Patsalos, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2019
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy ModelsKarine Leclercq, Alain Matagne, Laurent Provins, et al.
Seizure|February 5, 2003
Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsyHenrik Klitgaard, Alain Matagne, Renee Grimee, et al.
Epilepsy Research|January 25, 2015
Current understanding of the mechanism of action of the antiepileptic drug lacosamideMichael A Rogawski, Azita Tofighy, H Steve White, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Epilepsy Research|August 2, 2002
Use of epileptic animals for adverse effect testingHenrik Klitgaard, Alain Matagne, Yves Lamberty
Epilepsy Research|February 1, 2011
The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticusClaude G Wasterlain, Thomas Stöhr, Alain Matagne
European Journal of Pharmacology|May 18, 2011
Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant propertiesMichel Gillard, Bruno Fuks, Karine Leclercq, et al.
Brain Research Bulletin|August 30, 2008
Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in ratsDoru-Georg Margineanu, Alain Matagne, Rafal M Kaminski, et al.
Epilepsia|June 12, 2013
Synergism of lacosamide with established antiepileptic drugs in the 6-Hz seizure model in miceAlexey Shandra, Pavel Shandra, Olga Kaschenko, et al.
Epilepsy Research|September 28, 2002
Pilocarpine-induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterationsHenrik Klitgaard, Alain Matagne, Jocelyne Vanneste-Goemaere, et al.
Epilepsia|July 17, 2008
Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetamRafal M Kaminski, Alain Matagne, Philip N Patsalos, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2019
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy ModelsKarine Leclercq, Alain Matagne, Laurent Provins, et al.
Seizure|February 5, 2003
Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsyHenrik Klitgaard, Alain Matagne, Renee Grimee, et al.
Epilepsy Research|January 25, 2015
Current understanding of the mechanism of action of the antiepileptic drug lacosamideMichael A Rogawski, Azita Tofighy, H Steve White, et al.
Pageof 3